Our Aims
To develop objective imaging-based measures of uveitis activity which are:
-
- Reliable with high reproducibility;
-
- Sensitive even at low levels of inflammation;
-
- Discriminatory between different levels of inflammation.
To validate these outcome measures for adoption as the preferred endpoints in clinical trials in uveitis.
To provide practical clinical tools enabling their use as outcome measures in routine clinical practice.
The Challenge
One of the major challenges confronting those living with or working with uveitis is the lack of sensitive and objective markers of disease activity. This is a problem in both routine clinical practice and in the assessment of treatments for uveitis through clinical trials.
